Cargando…
Persistence and compliance with newly initiated antihypertensive drug treatment in patients with chronic kidney disease
BACKGROUND: Patients with chronic kidney disease initiating an antihypertensive drug (AH) treatment must persist and comply with it to slow disease progression and benefit from the reduction of cardiovascular morbidity and mortality. OBJECTIVES: This study evaluates the persistence and compliance wi...
Autores principales: | Truong, Viet Thanh, Moisan, Jocelyne, Kröger, Edeltraut, Langlois, Serge, Grégoire, Jean-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922779/ https://www.ncbi.nlm.nih.gov/pubmed/27382260 http://dx.doi.org/10.2147/PPA.S108757 |
Ejemplares similares
-
Association Between Loyalty to Community Pharmacy and Medication Persistence and Compliance, and the Use of Guidelines-Recommended Drugs in Type 2 Diabetes: A Cohort Study
por: Dossa, Anara Richi, et al.
Publicado: (2015) -
Factors associated with β-blocker initiation and discontinuation in a population-based cohort of seniors newly diagnosed with heart failure
por: Girouard, Catherine, et al.
Publicado: (2016) -
Initial Persistence With Antihypertensive Therapies Is Associated With Depression Treatment Persistence, But Not Depression
por: Schmittdiel, Julie A., et al.
Publicado: (2014) -
Effect of contraindicated drugs for heart failure on hospitalization among seniors with heart failure: A nested case-control study
por: Girouard, Catherine, et al.
Publicado: (2017) -
Non-persistence to antihypertensive drug therapy in Lithuania
por: Treciokiene, Indre, et al.
Publicado: (2022)